Emerald Advisers LLC decreased its stake in shares of Teladoc Health Inc (NYSE:TDOC) by 40.1% during the third quarter, HoldingsChannel reports. The firm owned 358,400 shares of the health services provider’s stock after selling 240,233 shares during the quarter. Teladoc Health makes up about 1.1% of Emerald Advisers LLC’s investment portfolio, making the stock its 29th largest position. Emerald Advisers LLC’s holdings in Teladoc Health were worth $24,271,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of TDOC. Westside Investment Management Inc. acquired a new position in Teladoc Health during the 2nd quarter valued at approximately $26,000. CENTRAL TRUST Co increased its stake in Teladoc Health by 82.6% during the 2nd quarter. CENTRAL TRUST Co now owns 378 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 171 shares in the last quarter. Meridian Wealth Management LLC acquired a new position in Teladoc Health during the 2nd quarter valued at approximately $27,000. Capital Investment Advisory Services LLC increased its stake in Teladoc Health by 800.0% during the 3rd quarter. Capital Investment Advisory Services LLC now owns 450 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 400 shares in the last quarter. Finally, Cornerstone Advisors Inc. increased its stake in Teladoc Health by 187.0% during the 2nd quarter. Cornerstone Advisors Inc. now owns 465 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 303 shares in the last quarter.
A number of analysts have recently weighed in on the stock. Piper Jaffray Companies set a $87.00 price objective on shares of Teladoc Health and gave the stock a “buy” rating in a research note on Friday, August 16th. JPMorgan Chase & Co. increased their price objective on shares of Teladoc Health from $82.00 to $83.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Deutsche Bank assumed coverage on shares of Teladoc Health in a research note on Thursday, September 12th. They issued a “buy” rating and a $76.00 price objective on the stock. Oppenheimer set a $83.00 price objective on shares of Teladoc Health and gave the stock a “buy” rating in a research note on Friday, September 6th. Finally, Craig Hallum increased their price objective on shares of Teladoc Health from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. Teladoc Health currently has an average rating of “Buy” and a consensus price target of $77.54.
Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.28) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.40) by $0.12. The firm had revenue of $137.96 million for the quarter, compared to analyst estimates of $136.46 million. Teladoc Health had a negative net margin of 20.15% and a negative return on equity of 11.20%. The business’s quarterly revenue was up 24.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.34) earnings per share. Equities analysts anticipate that Teladoc Health Inc will post -1.46 EPS for the current fiscal year.
In related news, SVP Andrew Turitz sold 9,158 shares of the firm’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $62.27, for a total transaction of $570,268.66. Following the sale, the senior vice president now owns 6,827 shares in the company, valued at $425,117.29. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Lewis Levy sold 675 shares of the firm’s stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $60.00, for a total transaction of $40,500.00. Following the sale, the insider now owns 4,805 shares in the company, valued at approximately $288,300. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 73,057 shares of company stock worth $5,336,085. 3.95% of the stock is owned by company insiders.
Teladoc Health Profile
Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
See Also: Why Dividend Stocks May Be Right for You
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.